SEC Comment Letter 0000000000-23-012709 to Immunome Inc. (IMNM) (CIK 0001472012) (IMNM)
Immunome Inc. (IMNM) (CIK 0001472012)
Date: Nov. 20, 2023 · CIK: 0001472012 · Accession: 0000000000-23-012709
AI Filing Summary & Sentiment
File numbers found in text: 333-275598
Letter
United States securities and exchange commission logo November 20, 2023 Sandra Stoneman Chief Legal Officer and General Counsel Immunome Inc. 665 Stockton Drive, Suite 300 Exton, PA 19341 Re:Immunome Inc. Registration Statement on Form S-3 Filed November 16, 2023 File No. 333-275598 Dear Sandra Stoneman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Dylan Kornbluth
Show Raw Text
United States securities and exchange commission logo
November 20, 2023
Sandra Stoneman
Chief Legal Officer and General Counsel
Immunome Inc.
665 Stockton Drive, Suite 300
Exton, PA 19341
Re:Immunome Inc.
Registration Statement on Form S-3
Filed November 16, 2023
File No. 333-275598
Dear Sandra Stoneman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Dylan Kornbluth